Gagnon Robert E.'s Form 4 filing
Opus Genetics, Inc. (IRD) · filed Sep 8, 2026
- Accession no.
- 0001140361-26-035912
- Filed
- Sep 8, 2026, 4:05 PM ET
- Trade date
- Sep 3, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $127.2K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gagnon Robert E.CIK 0001504983 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Common Stock | SSaleDisposed | −28,000 | $4.54 | −$127,212.4 | 556,375 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.